Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Bottomly

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Cancer Biology & Therapy|March 28, 2022
Functional proteomics of patient derived head and neck squamous cell carcinoma cells reveal novel applications of trametinibMyles Vigoda, Chase Mathieson, Nathaniel Evans, et al.
Blood|April 22, 2020
Discovery and characterization of targetable NTRK point mutations in hematologic neoplasmsSunil K Joshi, Kristin Qian, William H Bisson, et al.
Science Signaling|July 19, 2018
Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemiaChelsea Jenkins, Samuel B Luty, Julia E Maxson, et al.
Cell Death & Disease|March 17, 2022
Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphomaElana Thieme, Tingting Liu, Nur Bruss, et al.
Cancer Research|June 3, 2015
Therapeutically Targetable ALK Mutations in LeukemiaJulia E Maxson, Monika A Davare, Samuel B Luty, et al.
Blood|March 18, 2024
The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1β-mediated AML progressionHsin-Yun Lin, Mona Mohammadhosseini, John McClatchy, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
A Rapid Gene Expression Profiler Classifies AML Tumor Responsiveness to Standard TherapiesStephen E Kurtz, Christopher A Eide, Andy Kaempf, et al.
Molecular Cancer Research : MCR|March 28, 2023
Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid LeukemiaWilliam M Yashar, Brittany M Curtiss, Daniel J Coleman, et al.
Epigenetics|September 28, 2011
A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancerJacob Schwartzman, Solange Mongoue-Tchokote, Angela Gibbs, et al.
Blood Advances|November 28, 2022
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemiaCurtis A Lachowiez, Nicola Long, Jennifer Saultz, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Cancer Biology & Therapy|March 28, 2022
Functional proteomics of patient derived head and neck squamous cell carcinoma cells reveal novel applications of trametinibMyles Vigoda, Chase Mathieson, Nathaniel Evans, et al.
Blood|April 22, 2020
Discovery and characterization of targetable NTRK point mutations in hematologic neoplasmsSunil K Joshi, Kristin Qian, William H Bisson, et al.
Science Signaling|July 19, 2018
Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemiaChelsea Jenkins, Samuel B Luty, Julia E Maxson, et al.
Cell Death & Disease|March 17, 2022
Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphomaElana Thieme, Tingting Liu, Nur Bruss, et al.
Cancer Research|June 3, 2015
Therapeutically Targetable ALK Mutations in LeukemiaJulia E Maxson, Monika A Davare, Samuel B Luty, et al.
Blood|March 18, 2024
The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1β-mediated AML progressionHsin-Yun Lin, Mona Mohammadhosseini, John McClatchy, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
A Rapid Gene Expression Profiler Classifies AML Tumor Responsiveness to Standard TherapiesStephen E Kurtz, Christopher A Eide, Andy Kaempf, et al.
Molecular Cancer Research : MCR|March 28, 2023
Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid LeukemiaWilliam M Yashar, Brittany M Curtiss, Daniel J Coleman, et al.
Epigenetics|September 28, 2011
A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancerJacob Schwartzman, Solange Mongoue-Tchokote, Angela Gibbs, et al.
Blood Advances|November 28, 2022
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemiaCurtis A Lachowiez, Nicola Long, Jennifer Saultz, et al.
Pageof 6